Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Early research (Phase 1)Looking for participantsNCT06761651
What this trial is testing

TAVO412 in Patients with Cancer (TAVO412)

Who this might be right for
Cancer
Tavotek Biotherapeutics 50
Early research (Phase 1)Study completedNCT01238939
What this trial is testing

Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

Who this might be right for
Advanced Solid TumorsMetastatic Colorectal Cancer
Nippon Kayaku Co., Ltd. 35
Early research (Phase 1)Study completedNCT00783328
What this trial is testing

PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors

Who this might be right for
Neoplasms
Pfizer 13
Testing effectiveness (Phase 2)Study completedNCT00514267
What this trial is testing

An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors

Who this might be right for
Prostate CancerTumors
Astellas Pharma Inc 32
Early research (Phase 1)Active Not RecruitingNCT02389309
What this trial is testing

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Who this might be right for
Advanced Malignant Solid NeoplasmRecurrent Brain NeoplasmRecurrent Malignant Solid Neoplasm+1 more
M.D. Anderson Cancer Center 14
Testing effectiveness (Phase 2)Ended earlyNCT04278144
What this trial is testing

A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid Tumors

Who this might be right for
HER2-positive Solid TumorsHER2-positive Breast CancerHER2-positive Colorectal Cancer+2 more
Bolt Biotherapeutics, Inc. 175
Early research (Phase 1)Ended earlyNCT03954704
What this trial is testing

Study of Dalutrafusp Alfa (Formerly GS-1423) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Gilead Sciences 22
Not applicableStudy completedNCT04889144
What this trial is testing

PLAN Intervention to Enhance Engagement of Latino Cancer Patients in Advanced Care Planning

Who this might be right for
Locally Advanced Malignant Solid NeoplasmMetastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center 27
Testing effectiveness (Phase 2)Ended earlyNCT02576444
What this trial is testing

OLAParib COmbinations

Who this might be right for
Cancer
Joseph Paul Eder 67
Testing effectiveness (Phase 2)UnknownNCT05278364
What this trial is testing

Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerSolid Tumor
Shouyao Holdings (Beijing) Co. LTD 184
Early research (Phase 1)Looking for participantsNCT06477614
What this trial is testing

Anti-cancer DC Cell Vaccination to Treat Solid Tumors

Who this might be right for
Solid Tumor, AdultDC
Second Affiliated Hospital of Guangzhou Medical University 60
Early research (Phase 1)Study completedNCT01639911
What this trial is testing

Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors

Who this might be right for
Malignant Neoplasm of BreastCNS MalignancyMalignant Neoplasm of Gastrointestinal Tract+4 more
University of Illinois at Chicago 28
Early research (Phase 1)Looking for participantsNCT07269899
What this trial is testing

A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor CancerCancer
Sun Yat-sen University 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105021
What this trial is testing

Phase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid Tumor

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerColorectal Cancer+2 more
Affini-T Therapeutics, Inc. 100
Testing effectiveness (Phase 2)Looking for participantsNCT06112704
What this trial is testing

HS-20093 in Patients with Advanced Esophageal Carcinoma and Other Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Hansoh BioMedical R&D Company 220
Early research (Phase 1)UnknownNCT06232863
What this trial is testing

BH009 in Head and Neck Squamous Cell Carcinoma and Ovarian Cancer

Who this might be right for
Solid Tumor, Adult
Zhuhai Beihai Biotech Co., Ltd 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT07122063
What this trial is testing

Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid Tumors

Who this might be right for
Advanced Solid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 266
Early research (Phase 1)UnknownNCT02414516
What this trial is testing

A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Oncolys BioPharma Inc 17
Early research (Phase 1)Looking for participantsNCT06963281
What this trial is testing

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

Who this might be right for
Solid Tumors
Fortvita Biologics (USA)Inc. 285
Next Page